دورية أكاديمية
P1.01-112 Osimertinib vs Standard of Care (SoC) EGFR-TKI as First-Line Treatment in Chinese Patients With EGFRm Advanced NSCLC
| العنوان: | P1.01-112 Osimertinib vs Standard of Care (SoC) EGFR-TKI as First-Line Treatment in Chinese Patients With EGFRm Advanced NSCLC |
|---|---|
| المؤلفون: | Zhou, C., Cheng, Y., He, Y., Li, W., Zhang, H., Zhou, Q., Wang, B., Liu, C., Ramalingam, S., Walding, A., Saggese, M., Wang, J., Fan, M., Wu, Y. |
| المصدر: | In Journal of Thoracic Oncology October 2018 13(10) Supplement:S507-S508 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 15560864 |
|---|---|
| DOI: | 10.1016/j.jtho.2018.08.669 |